BlueRock Therapeutics logo

BlueRock Therapeutics

Striving to transform the treatment of disease by harnessing the power of cell therapy

478 employees · est. 2016 · Cambridge, United States

VS
Cell Care Therapeutics logo

Cell Care Therapeutics

Developing first-in-class stem cell derived biopharmaceuticals to treat inflammatory and degenerative ophthalmic diseases

7 employees · est. 2014 · Monrovia, United States

Cell Care Therapeutics is the older company (2016 vs 2014); BlueRock Therapeutics is the larger of the two.

Side-by-Side Comparison

BlueRock Therapeutics Cell Care Therapeutics
Founded
2016 2014 older
Headquarters
Cambridge, United States Monrovia, United States
Employees
478 larger 7
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Acquired Seed
Total Funding
$1.23B $5.30M
Funding Rounds
2 2
Services
Development of Cell Therapies, Clinical Trial Management, Research and Development Not tracked yet
Target Customers
Patients with Degenerative Diseases, Healthcare Providers, Medical Researchers Not tracked yet
Taxonomy
Cell Therapy, Clinical Stage Biotech, Neurological Diseases, Ophthalmic Diseases, Parkinson’s Disease, Photoreceptor Diseases, Induced Pluripotent Stem Cells (iPSC), Regenerative Medicine, Heart Muscle Regeneration, Myocardial Infarction Treatment, Chronic Heart Failure, Engineered Cell Therapy, Biopharmaceuticals, Stem Cell Therapeutics, Genome Medicine Biopharmaceuticals, Diabetic Macular Edema, Inflammatory Ophthalmic Diseases, Degenerative Ophthalmic Diseases, Secretome Platform, Mesenchymal Stromal Cells, Regenerative Immunotherapies, Exosomes, MicroRNAs, Protein Therapeutics, Scalable Manufacturing, Vision Loss Treatment, Stem Cell Derived Biologics, Ophthalmology
Website
bluerocktx.com cell-care.com
BlueRock Therapeutics logo

About BlueRock Therapeutics

BlueRock Therapeutics is a cutting-edge, clinical-stage cell therapy company dedicated to reshaping the landscape of disease treatment. Emphasizing the transformative potential of cell therapy, it has constructed a promising pipeline targeting severe neurological and ophthalmic conditions. Key clini...

Cell Care Therapeutics logo

About Cell Care Therapeutics

Cell Care Therapeutics, founded in 2014, is at the forefront of innovating stem cell-derived biopharmaceuticals. Specializing in the biopharma, biotechnology, and pharmaceutical industries, the company focuses on treating inflammatory and degenerative ophthalmic diseases. Their slogan, "Developing f...

We will tell you when either one moves

BounceWatch watches BlueRock Therapeutics and Cell Care Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BlueRock Therapeutics and Cell Care Therapeutics — by email.

Frequently Asked Questions

BlueRock Therapeutics — Striving to transform the treatment of disease by harnessing the power of cell therapy. Cell Care Therapeutics — Developing first-in-class stem cell derived biopharmaceuticals to treat inflammatory and degenerative ophthalmic diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BlueRock Therapeutics has raised $1.23B while Cell Care Therapeutics has raised $5.30M.
BlueRock Therapeutics and Cell Care Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BlueRock Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BlueRock Therapeutics on 9 Jun 2026, and Cell Care Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes